54741_Image_jpeg.jpg
A New Study Published in The Annals of Thoracic Surgery: Daxor’s BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in Use
April 19, 2018 09:00 ET | Daxor Corporation
New York, NY, April 19, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces the publication of new...
54741_Image_jpeg.jpg
Daxor to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
April 05, 2018 09:00 ET | Daxor Corporation
New York, NY, April 05, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will present at...
54741_Image_jpeg.jpg
Daxor to Exhibit at the American Association of Heart Failure Nurses 2018 Advanced Heart Failure Symposium
March 22, 2018 09:00 ET | Daxor Corporation
New York, NY, March 22, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will exhibit for the...
54741_Image_jpeg.jpg
New Data Showing Patient Care Individualized by Daxor’s Precision Blood Volume Analysis Reduces Heart Failure Readmissions by 56% and Mortality by over 80% Presented at the American College of Cardiology 2018 Annual Scientific Session
March 14, 2018 08:00 ET | Daxor Corporation
(NYSE MKT LLC: DXR) New York, NY, March 14, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations,...
54741_Image_jpeg.jpg
Daxor Corporation Announces Positive New Critical Care Research Highlighting Benefit from BVA Use; Daxor Corporation to Exhibit at the American College of Cardiology 2018 Annual Meeting (NYSE MKT LLC: DXR)
March 09, 2018 11:55 ET | Daxor Corporation
New York, NY, March 09, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, exhibited at the 2018 Society for...
54741_Image_jpeg.jpg
Daxor Corporation Announces Rise in Kit Sales, New Device Sale, and Filing of Form N-CSR for 2017 (NYSE MKT LLC: DXR)
March 08, 2018 12:56 ET | Daxor Corporation
New York, NY, March 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, filed a Form N-CSR disclosing its...
54741_Image_jpeg.jpg
DAXOR CORPORATION REVISES 2017 DIVIDEND
December 28, 2017 16:09 ET | Daxor Corporation
New York, NY, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, revises the record date and...
54741_Image_jpeg.jpg
DAXOR CORPORATION ANNOUNCES 2017 DIVIDEND
December 21, 2017 06:00 ET | Daxor Corporation
New York, NY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announced the payment of a...
54741_Image_jpeg.jpg
Daxor Corporation Announces Share Buyback Program
November 01, 2017 09:00 ET | Daxor Corporation
New York, NY, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announced today that an updated...